SOTS 2nd Hour: Meta Expectations, Fed in Focus, and the View From The C-Suite – w/GSK & Hershey CEOs 7/30/25
Squawk on the Street
00:00
Pharmaceutical Growth and Innovation
This chapter explores the remarkable performance of a pharmaceutical company, highlighting significant sales increases in specialty medicines, particularly in oncology and respiratory treatments. The discussion covers the anticipated FDA approvals for groundbreaking drugs and the impact of regulatory changes, including tariffs, on the industry. Additionally, the chapter emphasizes the company's commitment to innovation and proactive supply chain strategies in the U.S. market.
Transcript
Play full episode
